Exchange: NASDAQ·Updated 07:42 PM EDT
ICU logo

ICU SeaStar Medical Holding Corp

$2.98
$0.0699
(2.40%)
Today
Closed $2.98
$0.0499
(1.68%)
After Hours
Mkt Cap$88.23M
Vol25,537.00

About ICU

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
37

Bearish Sentiment

How do you feel about ICU?

Advertisement|Remove ads.